pramipexole


Also found in: Dictionary, Wikipedia.

pramipexole

 [pram″ĭ-pek´sōl]
a dopamine agonist used in the form of the dihydrochloride salt in treatment of parkinson's disease, administered orally.

pramipexole

/pram·i·pex·ole/ (pram″ĭ-pek´sōl) a dopamine agonist used in the form of the dihydrochloride salt as an antidyskinetic in the treatment of Parkinson's disease.

pramipexole

(prăm′ə-pĕk′sōl′)
n.
A dopamine agonist used in the treatment of Parkinson's disease.

pramipexole

an antiparkinson agent.
indication It is used to treat parkinsonism.
contraindication Known hypersensitivity prohibits its use.
adverse effects Life-threatening effects are hemolytic anemia, leukopenia, and agranulocytosis. Other adverse effects include psychosis, hallucination, depression, dizziness, constipation, impotence, and blurred vision. Common side effects include agitation, insomnia, nausea, anorexia, and orthostatic hypotension.

pramipexole

Mirapex® Neurology A dopamine antagonist used to manage Parkinson's disease Adverse effects Constipation, dry mouth, vision defects, insomnia
References in periodicals archive ?
Pramipexole Dihydrochloride Tablets, the generic version of Mirapex, is available in 0.
Reddy's Laboratories (NYSE:RDY) revealed on Wednesday the availability of the US Food & Drug Administration (USFDA) approved PRAMIPEXOLE dihydrochloride extended-release tablets 0.
Pramipexole is a dopamine agonist that has been approved by the FDA for the treatment of restless legs syndrome.
After 12 h cultured, the cells were treated with 10 [micro]mol/L pramipexole (Sigma, St.
A 6-month double-blind study of 234 patients using pramipexole found that 9.
While both iron and pramipexole are established treatments for restless legs syndrome (RLS), the new study (n = 30) was the first randomized trial to compare them head to head.
For instance, in October 2012, Boehringer-Ingelheim and the Institute of Drug Technology (Farmanguinhos) agreed on a partnership for the local production of Pramipexole for Parkinson's disease treatment.
For one group (3 women, 9 men) pramipexole, levodopa and amantadine, and for another group (4 women, 8 men) trihexiphenidyle, levodopa and amantadine were prescribed respectively by the physician.
For example, drugs to treat Parkinson's disease, including ropinirole (Requip) and pramipexole (Mirapex), also have FDA approval to treat moderate-to-severe RLS.
Pramipexole, the dopamine agonist approved for treating Parkinson's disease and restless legs syndrome, may be associated with an increased risk for heart failure, according to a statement issued by the Food and Drug Administration.
I have been told there's no cure but I went to the doctor and he gave me pramipexole tablets, which are no good.
Two, ropinirole (Requip) and pramipexole (Mirapex), are approved for the treatment of RLS by the FDA.